Detalhe da pesquisa
1.
Mutant KRAS modulates colorectal cancer cells invasive response to fibroblast-secreted factors through the HGF/C-MET axis.
Int J Cancer
; 151(10): 1810-1823, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869872
2.
The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
IUBMB Life
; 73(5): 761-773, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615655
3.
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.
Front Immunol
; 14: 1259197, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022684
4.
Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS.
Cells
; 11(16)2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010567
5.
Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors.
Cells
; 11(13)2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805073
6.
Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors.
Cancers (Basel)
; 11(12)2019 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847096
7.
KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment.
Cancer Res
; 78(1): 7-14, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263151
8.
The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis.
Cells
; 7(2)2018 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463063